| PE15.03 | Analysis of IgG1 and IgG3 humoral response against the membrane proximal external region of HIV-1 envelope glycoprotein | E-poster | Humoral immunity |
| PU14.02 | Analysis of pre-ART MiSeq multiplexed longitudinal datasets demonstrated the env gene region as the most reliable for timing the entry of the virus into the reservoir | Publication Only | HIV sequencing insights including viral diversity and antiretroviral resistance |
| OA14.03 | Analysis of the early responses to HIV-1 in matched treatment naïve individuals reveals early soluble proteins that are associated with in vivo virus control | Oral Abstract Session | Innate and trained immunity |
| PE02.05 | Antibody genetic diversity with large structural variation in a South African population | E-poster | Broadly neutralizing antibodies |
| OA08.01 | Antibody isotype switching as a mechanism to counter HIV neutralization escape | Oral Abstract Session | Humoral immunity |
| PE02.03 | Antibody-Antigen Distance of Broadly Neutralizing HIV-1 Antibodies Correlates with Glycan-Shield Coverage of HIV-1 Envelope Trimer | E-poster | Broadly neutralizing antibodies |
| PE08.05 | Anti-CCR5 siRNA-loaded polymeric nanoparticles for topical pre-exposure prophylaxis | E-poster | Delivery technologies: novel approaches, formulation and multi-purpose |
| OA09.02 | Anti-Env antibody-independent protection of repeated intrarectal low-dose SIVmac239 challenges in rhesus macaques by vaccination inducing Gag/Vif-specific CD8+ T but not CD4+ T cells | Oral Abstract Session | Mucosal immunity |
| PE08.09LB | Anti-HPV and anti-HSV activity in rectal enema effluents collected from subjects receiving PC-1005: a dual compartment multipurpose prevention technology formulation | E-poster | Delivery technologies: novel approaches, formulation and multi-purpose |
| OA09.04 | Applying insights from HIV to guide the development of a T-cell vaccine for SARS-CoV-2 | Oral Abstract Session | COVID research: Applying lessons from HIV prevention to SARS CoV-2 |